Evidence map›Paper›PMID 41400384›Full record

ArticlemSphere2026

Stationary-phase

Patricia J Hare, Juliet R González, Wendy W K Mok

Abstract read
In one paragraph

Article in mSphere, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. The Role of the SOS Response in the Adaptation ofCurrent issues in molecular biology · 2026
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Patricia J HareDepartment of Molecular Biology and Biophysics, UConn Health, Farmington, Connecticut, USA.ORCID 0000-0001-5014-6161
Juliet R GonzálezDepartment of Molecular Biology and Biophysics, UConn Health, Farmington, Connecticut, USA.
Wendy W K MokDepartment of Molecular Biology and Biophysics, UConn Health, Farmington, Connecticut, USA.ORCID 0000-0002-6638-2959

Funding

Skeletal, Craniofacial and Oral Biology Training GrantT90DE021989 · NIDCR · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI MINA, MINA · 2011 to 2022
$4.5M
Mapping polymicrobial interactions that modulate antibiotic persistenceDP2GM146456 · NIGMS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI MOK, WENDY W.K. · 2021 to 2021
$1.5M
Bacterial Reprogramming that Contributes to Antibiotic Persistence toward Topoisomerase InhibitorsR01AI167886 · NIAID · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI Wendy W.K. Mok · 2024 to 2026
$1.4M
Mapping polymicrobial interactions that modulate antibiotic persistenceDP2AI183154 · NIAID · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI MOK, WENDY W.K. · 2024 to 2024
$984k
Molecular Mechanisms of Pseudomonas aeruginosa Antibiotic Persistence in Monocultures and Microbial CommunitiesF30DE032598 · NIDCR · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI Patricia Jin Hare · 2023 to 2026
$164k
NIAID NIH HHS DP2 AI183154NIAID NIH HHS R01 AI167886NIDCR NIH HHS F30 DE032598NIDCR NIH HHS F30DE032598NIDCR NIH HHS T90 DE021989NIGMS NIH HHS DP2 GM146456NIH HHS R01AI167886, DP2GM146456
6 · The paper itself

Abstract

When susceptible bacterial cultures are treated with antibiotics, some cells can survive treatment without heritable resistance, giving rise to susceptible daughter cells in a phenomenon termed antibiotic persistence. Current models of fluoroquinolone (FQ) persistence in stationary-phase cultures posit that post-treatment resuscitation is dependent on double-stranded break (DSB) repair through RecA-mediated homology-directed repair. Previously, we reported that stationary-phase IMPORTANCE:

Indexed as

Anti-Bacterial AgentsDNA Breaks, Double-StrandedFluoroquinolonesPseudomonas aeruginosaDNA RepairDrug Resistance, BacterialLevofloxacinMicrobial Sensitivity TestsMicrobial ViabilityRec A RecombinasesAnti-Bacterial AgentsFluoroquinolonesLevofloxacinRec A RecombinasesDNA damagepersistencePseudomonas aeruginosatolerance

Identifiers

PMID41400384
PMCPMC12838390

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.